Thinking | T. Rowe Price

Contact Us

Our collected views...

Our relationships with US companies have always been strong. And still are today.

Polls & Policy Perspectives

Our team of experts will share their views as this critical year progresses.

All Asset Classes
Equity
Fixed Income
Multi-Asset

All Regions
Global
Europe
Asia Pacific
Emerging Mkts
US

This Quarter ( ) Hide

December 2024 / From the Field

A deeper look at flexible credit strategies and the critical role of...

A deeper look at flexible credit strategies and the critical role of manager...

A deeper look at flexible credit strategies...

Multi-asset credit strategies leverage flexibility to different degrees. Learn how...

By Camila Henao Arbelaez, Som Priestley & Christopher Tarui

By Camila Henao Arbelaez, Som Priestley & Christopher Tarui

6 December 2024 / From the Field

Growth or value - Why choose when you can have core

Growth or value? Why choose when you can have core?

Growth or value? Why choose when you can...

Making stock selection the main driver of excess returns.

By Peter J. Bates

Peter J. Bates Portfolio Manager

November 2024 / From the Field

Disciplined investing amid a dynamic US market environment

Disciplined investing amid a dynamic U.S. market environment

Disciplined investing amid a dynamic U.S....

Looking toward 2025, U.S. equity market returns are likely to be harder earned.

By Justin P. White

Justin P. White Portfolio Manager

November 2024 / On the Horizon

AI’s “easy money” era is over, but rich opportunities remain

AI’s “easy money” era is over, but an abundance of opportunities remain

AI’s “easy money” era is over, but an abundance...

Artificial intelligence is set to be one of the biggest productivity enhancers for...

November 2024 / On the Horizon

Mapping the path from slowdown to recovery

Mapping the path from slowdown to recovery

Mapping the path from slowdown to recovery

The world is transitioning to manufacturing-led growth.

By Nikolaj Schmidt

Nikolaj Schmidt Chief Global Economist

27 August 2024 / From the Field

Could GLP-1s help rebalance the food trilemma?

Could GLP-1s help rebalance the food trilemma?

Could GLP-1s help rebalance the food trilemma?

Anti-obesity medications could play a key role in balancing the food trilemma.

By Maria Elena Drew & Daniel Ryan

By Maria Elena Drew & Daniel Ryan